Well, isn't THAT interesting?
It says:
"In both groups, 80% of participants reported using non-steroidal anti-inflammatory drugs (NSAIDs) intermittently for pain (<4 times per week), and 20% reported using NSAIDs more regularly (>4 times per week)."
The abstract for the nursing meeting -- the one with the "miracle" results that now have magically transformed into more "reasonable" numbers -- bragged:
"Pain medication consumption decreased by 50% in the Scrambler group but not in the Sham group. Allodynia was reduced from 77% to 15% in the Scrambler group at 3 weeks."
However, NOWHERE does this new paper even mention allodynia, much less reducing it. And the authors go to the trouble of telling everyone how much analgesics the patients BEFORE the therapy, but evidently didn't bother to measure how much they were taking AFTERWARDS!
Isn't that CURIOUS? Relieving allodynia could be a SIGNIFICANT selling factor for calmares, but it's not even mentioned. Ditto for reducing analgesic use, but they DIDN'T measure THAT! They also didn't mention whether any of the patients took opioids or not! Rdeucing the use of THOSE would also be a BIG selling point! gee! I wonder WHY they didn't -- don't you?
